Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma

Table 2 Assay of laboratory prepared mixture of remdesivir and levodropropizine by the suggested flourimetric approach

Laboratory prepared mixture(ng/mL)		Recovery%^*
Remdesivir	Levodropropizine	Remdesivir	Levodropropizine
25	15	101.74	99.13
50	30	100.48	99.90
75	45	100.60	98.47
100	60	101.59	100.94
125	75	101.62	99.97
100	100	101.02	98.52
Mean ± RSD%		101.17 ± 0.551	99.49 ± 0.964

ISSN: 2661-801X